Can Propylene Glycol Cause a High Anion Gap?
What propylene glycol is and where it is used
Propylene glycol is a carrier and carrier employed in a range of medical and nonmedical products. In clinical environments, it is most important because it can appear in IV medications, especially certain sedatives and other formulations that need a liquid base. It can also be found in some oral products and topical products. Most exposures are harmless, but large or prolonged exposure can create a toxicity problem, especially in hospitalized patients.
This is important because propylene glycol is not just an ingredient; it is a compound that is metabolized by the body into other substances. Under the right situations, those metabolites can affect acid-base balance and lead to abnormal serum chemistry findings. In some patients, the clinical picture includes high anion gap findings, especially when the exposure is significant or renal clearance is impaired.
From a diagnostic evaluation standpoint, propylene glycol exposure is often overlooked unless the medication list is reviewed closely. That is why laboratory interpretation must be paired with clinical correlation. The product source, route of exposure, and duration all influence whether propylene glycol becomes clinically relevant.
How the anion gap is calculated
The anion gap is a calculated value used to detect certain patterns of metabolic acidosis. It reflects the variation between observed cations and observed anions in the blood. The usual anion gap formula uses serum sodium, serum chloride, and serum bicarbonate.
A basic version is:
anion gap = serum sodium − (serum chloride + serum bicarbonate)An anion gap calculator performs this computation and can assist clinicians and patients see whether the result sits in a normal interval or points to an acid-base problem. Because the result relies on the measured electrolyte values, even small electrolyte variations can alter the number.
The anion gap is helpful because unmeasured anions can increase in the blood during conditions such as lactic acidosis, ketoacidosis, or toxin ingestion. When interpreting the number, clinicians also consider albumin, since low albumin can reduce the measured gap and hide a clinically important disturbance. That is why the albumin-corrected anion gap is often more informative than the unadjusted value.
Why propylene glycol can elevate the anion gap
Yes, propylene glycol can result in a high anion gap in the setting of propylene glycol toxicity. The mechanism is usually secondary rather than sudden. After exposure, propylene glycol is metabolized into acidic compounds, including organic acids, which can contribute to high anion gap metabolic acidosis. In addition, the body may develop a simultaneous lactic acidosis, which additionally increases the gap.
Another important clue is the osmolar gap. Propylene glycol itself elevates serum osmolarity, so early toxicity may present with an elevated osmolar gap before the anion gap rises. As metabolism proceeds, the parent compound drops while acidic metabolites build up, shifting the pattern from isolated osmolar gap elevation to a combined osmolar gap and high anion gap picture.
This progression is why the point in time of testing matters. A patient may initially have a high osmolar gap and later show progressive acidosis, elevated lactate, and a rising anion gap. In other words, propylene glycol can be part of a mixed laboratory pattern that changes over time.
Typical causes of increased anion gap metabolic acidosis
Propylene glycol is just one potential cause of metabolic acidosis. A wide differential diagnosis is necessary whenever the anion gap is elevated. Typical causes include ketoacidosis, lactic acidosis, renal failure, and use of toxic alcohols. Each of these can cause a similar lab pattern, but the underlying mechanism is different.
Ketoacidosis is often seen with diabetes, starvation, or prolonged vomiting, while lactic acidosis may occur with shock, sepsis, hypoperfusion, or certain drugs and toxins. Renal failure can raise the gap because the kidneys cannot clear acid effectively, allowing unmeasured acids to accumulate. Toxic alcohols, such as methanol or ethylene glycol, can also produce an elevated anion gap and osmolar gap pattern.
This is why laboratory interpretation should never rely on a single number alone. The anion gap calculator can identify a worrisome result, but the final diagnosis depends on the clinical context, medication exposure, and additional testing.
Indicators and signs of propylene glycol toxicity
The clinical signs of propylene glycol toxicity can be vague at first. Patients may present with altered mental status, hypotension, and tachypnea as the acid-base disturbance worsens. Tachypnea often reflects respiratory compensation for acidosis. Some patients may also show signs of reduced perfusion or sedation, depending on the degree of exposure and the agents used.
A rising serum lactate can be an important clue, especially when the clinical picture suggests an unexplained acid-base disorder. Elevated lactate does not confirm propylene glycol as the cause, but it strengthens concern when combined with medication exposure, abnormal serum chemistry, and a high anion gap. Because the signs overlap with other illnesses, clinical correlation is essential.
Severe cases can progress quickly, particularly when the patient has reduced clearance or multiple risk factors. A careful review of medications, infusion history, and serial labs is often the fastest way to recognize the problem.
Laboratory tests for assessing suspected poisoning
If propylene glycol exposure is suspected, the assessment usually includes serum osmolality, calculation of the osmolar gap, a blood gas, and checking of renal function. These measures help determine whether the patient has a mixed toxic and metabolic picture.
Serum osmolality is compared with the calculated osmolarity to identify an osmolar gap. A high gap suggests unmeasured osmotically active substances, which may include propylene glycol or other toxic alcohols. The blood gas helps define the severity of the acid-base disorder and shows whether the patient has metabolic acidosis with respiratory compensation. Renal function testing is important because reduced clearance can worsen toxicity and prolong exposure.
Additional labs often include serum lactate, electrolytes, and repeat chemistry panels. Serial testing can show whether the anion gap is rising or resolving after intervention. Often, the pattern of serum chemistry abnormalities provides the strongest evidence before specialized toxin levels are available.
How to read an Anion Gap Calculator finding
An anion gap calculator is useful, but the finding should carefully be interpreted in context. First, confirm whether the value is in the normal range for the lab used. Normal ranges can vary slightly depending on the analyzer and whether potassium is included in the formula. A result that is borderline in one lab may be definitely out of range in another.
Then, evaluate the possibility of hypoalbuminemia. As albumin is a major unmeasured anion, low albumin can mask a true acidosis. Click for more info An albumin-corrected anion gap gives a more accurate estimate of the underlying acid burden when albumin is reduced. This adjustment is most useful in critically ill patients, where albumin is often low.
In the end, ask whether the result fits the overall picture. A high anion gap with normal lactate and normal ketones may point toward a toxin, while a high gap with elevated lactate may indicate tissue hypoperfusion, sepsis, or propylene glycol toxicity. Good interpretation depends on clinical context, not just the number.
When propylene glycol exposure becomes dangerous
The risk rises with dose-related toxicity, longer exposure, and reduced ability to remove the compound. This is particularly important with some benzodiazepines and other intravenous medications that include propylene glycol as a solvent. Ongoing or high-dose infusion can result in accumulation over time.
Renal impairment increases risk because the kidneys have a key role in clearing the compound and its byproducts. If renal clearance is reduced, propylene glycol and its metabolites may accumulate, contributing to osmolar gap elevation, lactic acidosis, and high anion gap metabolic acidosis.
Risk is highest when multiple factors stack together: high medication dose, prolonged infusion, critical illness, dehydration, and impaired kidney function. In that setting, monitoring should be more regular and clinicians should maintain a high index of suspicion for toxicity.
Treatment and management of suspected propylene glycol toxicity
The first step in management is discontinuation of the suspected source. Stopping the offending medication or exposure can prevent further accumulation. Depending on the severity of the case, the patient may also need supportive care, including fluid resuscitation, correction of electrolyte abnormalities, and treatment of acidosis.
Monitoring is essential after the exposure is stopped. Serial serum chemistry testing, blood gas assessment, serum lactate, and renal function checks help show whether the acid-base disorder is improving. If the patient has severe symptoms, rapidly worsening acidosis, or significant renal dysfunction, more aggressive treatment may be needed.
Hemodialysis can be considered in severe cases because it helps remove propylene glycol and correct associated metabolic derangements. It may be especially useful when there is significant acidosis, hemodynamic instability, or impaired renal clearance. The decision is based on the full clinical picture rather than the anion gap alone.
When to require prompt medical evaluation
Prompt evaluation is warranted if there are acute danger signs such as progressive confusion, profound weakness, respiratory distress, collapse, or shock symptoms. A patient with suspected toxic exposure and a quickly evolving condition should not wait for scheduled review.
Worrisome findings include severe acidosis, markedly low bicarbonate, sustained hypotension, or quickly rising lactate. These findings may signal a severe acid-base disorder that needs immediate treatment. If propylene glycol exposure is possible, a prompt medical assessment can identify whether the patient needs hospital monitoring, medication changes, or hemodialysis.
Since this condition can overlap with other causes of high anion gap metabolic acidosis, clinicians should evaluate the entire presentation early. Rapid assessment of medication exposure, serum osmolality, blood gas results, and renal function can prevent delays in care.
Frequently asked questions about propylene glycol and the anion gap
Can propylene glycol cause a high anion gap?
It can. Propylene glycol can cause a high anion gap, especially when exposure is marked or prolonged. It may first raise the osmolar gap and then, as it is metabolized into acidic metabolites, contribute to high anion gap metabolic acidosis and lactic acidosis.
What is the difference between an anion gap and an osmolar gap?
The anion gap shows unmeasured charged particles and helps identify causes of metabolic acidosis. The osmolar gap reflects the difference between measured and calculated osmolarity and suggests unmeasured dissolved substances, such as propylene glycol or other toxic alcohols. Both are important, but they answer different questions.
Which medications contain propylene glycol?
Propylene glycol can be found in some intravenous medications, including certain benzodiazepines, sedatives, and other formulations that use it as a solvent. It may also appear in some oral products and topical products. The exact formulation depends on the drug and manufacturer, so the medication list should be reviewed carefully.
What indications suggest propylene glycol toxicity?
Potential manifestations include altered mental status, hypotension, increased respiratory rate, and indications of worsening acidosis. A elevated serum lactate may also be noted. Since these findings are non-specific, they must be evaluated with history of exposure, lab findings, and total clinical correlation.

How is propylene glycol toxicity treated?
Treatment usually starts with discontinuation of the source and supportive care. Clinicians monitor the patient closely with repeat labs, including blood gas, serum chemistry, and renal function. In serious cases, hemodialysis may be used to eliminate the toxin and improve severe acidosis.